-
Symbol
-
CLDI on NYSE
-
Investment type
-
Equity / Common Stock, $0.0001 par value
-
Latest Disclosed Ownership
-
730K shares
-
Security Ownership
-
14.5%
Lincoln Alternative Strategies LLC ownership in Calidi Biotherapeutics, Inc. Common Stock, $0.0001 par value (CLDI)
2025-08-27 - Lincoln Alternative Strategies LLC has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 730K shares of Calidi Biotherapeutics, Inc. Common Stock, $0.0001 par value (CLDI).
This represents 14.5% percent ownership of the company.